PLASMA FIBRONECTIN DURING L-ASPARAGINASE THERAPY OF PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA

被引:0
|
作者
HOFELER, H [1 ]
KEMPER, J [1 ]
ANDERS, CU [1 ]
机构
[1] UNIV KLIN ESSEN,W DEUTSCH TUMORZENTRUM,D-4300 ESSEN,FED REP GER
来源
BLUT | 1985年 / 51卷 / 03期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:212 / 212
页数:1
相关论文
共 50 条
  • [21] EFFECT OF L-ASPARAGINASE ON CARBOHYDRATE-METABOLISM IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    MINIERO, R
    PASTORE, G
    DIMONTEZEMOLO, LC
    DELPREVER, AB
    SARACCO, P
    CERUTTI, F
    CONROTTO, M
    HAEMATOLOGICA, 1984, 69 (04) : 428 - 434
  • [22] BLOOD-COAGULATION CHANGES IN PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) TREATED WITH L-ASPARAGINASE
    LEGNANI, C
    PALARETI, G
    PESSION, A
    POGGI, M
    BURNELLI, R
    COCCHERI, S
    THROMBOSIS RESEARCH, 1986, : 40 - 40
  • [23] HYPERGLYCEMIA, KETOACIDOSIS AND OTHER COMPLICATIONS OF L-ASPARAGINASE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    CETIN, M
    YETGIN, S
    KARA, A
    TUNCER, AM
    GUNAY, M
    GUMRUK, F
    GURGEY, A
    JOURNAL OF MEDICINE, 1994, 25 (3-4) : 219 - 229
  • [24] L-Asparaginase Treatment in Acute Lymphoblastic Leukemia
    Pieters, Rob
    Hunger, Stephen P.
    Boos, Joachim
    Rizzari, Carmelo
    Silverman, Lewis
    Baruchel, Andre
    Goekbuget, Nicola
    Schrappe, Martin
    Pui, Ching-Hon
    CANCER, 2011, 117 (02) : 238 - 249
  • [25] Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphoblastic leukemia
    Elhasid, R
    Lanir, N
    Sharon, R
    Ben Arush, MW
    Levin, C
    Postovsky, S
    Ben Barak, A
    Brenner, B
    BLOOD COAGULATION & FIBRINOLYSIS, 2001, 12 (05) : 367 - 370
  • [26] EFFECT OF L-ASPARAGINASE THERAPY FOR ACUTE LYMPHOBLASTIC-LEUKEMIA ON PLASMA VITAMIN-K-DEPENDENT COAGULATION-FACTORS AND INHIBITORS
    BEZEAUD, A
    DROUET, L
    LEVERGER, G
    GRIFFIN, JH
    GUILLIN, MC
    JOURNAL OF PEDIATRICS, 1986, 108 (05): : 698 - 701
  • [27] FACTOR-VIII VONWILLEBRAND-FACTOR ABNORMALITIES DURING L-ASPARAGINASE TREATMENT IN PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    CASONATO, A
    LAZZARO, AR
    ROSOLEN, A
    GIROLAMI, A
    ACTA HAEMATOLOGICA, 1988, 80 (04) : 190 - 193
  • [28] A REGIMEN FOR ANTITHROMBIN-III SUBSTITUTION IN PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA UNDER TREATMENT WITH L-ASPARAGINASE
    BELMONTE, MM
    GUGLIOTTA, L
    DELVOS, U
    CATANI, L
    VIANELLI, N
    CASCIONE, ML
    BELARDINELLI, AR
    MOTTOLA, L
    TURA, S
    HAEMATOLOGICA, 1991, 76 (03) : 209 - 214
  • [29] SEQUELAE OF THROMBOTIC OR HEMORRHAGIC COMPLICATIONS FOLLOWING L-ASPARAGINASE THERAPY FOR CHILDHOOD LYMPHOBLASTIC-LEUKEMIA
    OTT, N
    RAMSAY, NKC
    PRIEST, JR
    LIPTON, M
    PUI, CH
    STEINHERZ, P
    NESBIT, ME
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1988, 10 (03): : 191 - 195
  • [30] THYROID-FUNCTION DURING L-ASPARAGINASE THERAPY IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - DIFFERENCE BETWEEN INDUCTION AND LATE INTENSIFICATION
    FERSTER, A
    GLINOER, D
    VANVLIET, G
    OTTEN, J
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1992, 14 (03): : 192 - 196